A statement released earlier today by N+1 Singer about Genus PLC (LON:GNS) raises the target price to 2,019.00GBX
- Updated: September 19, 2016
Displaying a price of 2,000.00GBX, Genus PLC (LON:GNS) traded 0.50% higher on the day. With the last stock close up 21.52% relative to the two hundred day moving average, compared with the S&P 500 Index which has fallen -0.01% over the same time period. The company has been tracking to a 50-day moving average of 1,884.72GBX and 200-day average of 1,644.94GBX. Volume of trade was was down over the average, with 45,809 shares of GNS changing hands under the typical 75,168 shares.
In a report released on Tuesday September 20 2016 N+1 Singer increased the target price of Genus PLC (LON:GNS) from 1,429GBX to 2,019GBX stating a possible upsideof 0.01%.
Previously on Friday September 9 2016, Liberum Capital reported about Genus PLC(LON:GNS) raised the target price from 0.00GBX to 1,950.00GBX. At the time, this suggested an upside of 0.06%.
A total of 5 brokerages have issued a ratings update on the company. One firm rate the stock a strong buy, one analyst rate the stock a buy, four analyts rate the stock a hold, 0 rate the stock to underperform, and lastly 0 analystsrate the stock as sell with a one year target stock price of 1,485.60GBX
With a market capitalization of 0.0 GBX, Genus PLC has a 52 week low of 1,281.00GBX and a 52 week high of 2,056.00GBX with a price-earnings ratio of 25.
More About Genus PLC (LON:GNS)
Genus plc is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments are Genus PIC, Genus ABS and Genus Asia. The Genus PIC segment serves porcine customers in North America, Latin America and Europe. The Genus ABS segment serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment serves porcine, dairy and beef customers in Asian markets. The Company breeds and distributes genes of pigs and bulls. In the porcine market, the Company sells genetically boars and sows that produce offspring with characteristics, such as growth or leaner meat. In the dairy and beef markets, the Company’s primary product is bull semen, which is delivered through artificial insemination. The Company also offers genetically superior embryos through its subsidiary, and In Vitro Brasil S.A.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.